Standout Papers
- MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy (2017)
- Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer (2009)
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer (2010)
- The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 (2019)
Immediate Impact
4 by Nobel laureates 7 from Science/Nature 85 standout
Citing Papers
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
2022 Standout
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
Works of Xavier Pivot being referenced
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
2019 Standout
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xavier Pivot | 8454 | 4100 | 2875 | 372 | 11.4k | |
| Joyce O’Shaughnessy | 10008 | 3769 | 4254 | 341 | 13.6k | |
| P. Fumoleau | 9431 | 2609 | 4272 | 324 | 14.0k | |
| Sabino De Placido | 7699 | 4412 | 3698 | 376 | 13.7k | |
| Patrick Neven | 8402 | 4816 | 4330 | 486 | 15.2k | |
| George R. Blumenschein | 6894 | 4981 | 2383 | 324 | 11.7k | |
| Alberto Ocaña | 7114 | 2462 | 2453 | 296 | 12.0k | |
| Jean-Marc Ferrero | 6284 | 3884 | 2928 | 207 | 9.3k | |
| Luc Dirix | 9210 | 3359 | 4490 | 305 | 14.2k | |
| Christophe Massard | 6877 | 5908 | 2422 | 426 | 12.3k | |
| Sjoerd Rodenhuis | 5971 | 4238 | 3355 | 253 | 12.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...